ZYSC(600280)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥637,840,637.27, representing a decrease of 7.01% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of ¥29,099,792.28, a decline of 374.11% year-over-year[4]. - The basic and diluted earnings per share were both -¥0.026, reflecting a decrease of 388.89% year-over-year[4]. - Net profit for Q1 2023 was a loss of ¥30,638,786.69, compared to a profit of ¥7,171,907.04 in Q1 2022, indicating a significant decline[16]. - The operating profit for Q1 2023 was a loss of ¥5,010,677.60, contrasting with a profit of ¥35,933,623.63 in Q1 2022[15]. - The company reported a total comprehensive income of ¥26,732,845.11 for Q1 2023, compared to ¥43,941,048.12 in Q1 2022[26]. Cash Flow - The net cash flow from operating activities increased by 370.72%, amounting to ¥165,546,349.77[4]. - In Q1 2023, the net cash flow from operating activities was ¥165,546,349.77, a significant increase from ¥35,168,545.39 in Q1 2022, representing a growth of 370.5%[18]. - Total cash inflow from operating activities was ¥1,903,637,064.73, while cash outflow was ¥1,738,090,714.96, resulting in a net cash inflow of ¥165,546,349.77[18]. - The company reported a decrease in cash inflow from financing activities to ¥400,025,555.55 in Q1 2023, down from ¥720,000,000.00 in Q1 2022, a decline of 44.4%[19]. - Cash and cash equivalents at the end of Q1 2023 amounted to ¥179,376,641.01, compared to ¥306,269,987.22 at the end of Q1 2022, reflecting a decrease of 41.5%[19]. - Cash flow from operating activities for Q1 2023 was ¥59,936,384.40, a significant improvement from a negative cash flow of -¥17,197,720.16 in Q1 2022[28]. Assets and Liabilities - Total assets at the end of the reporting period were ¥12,210,396,757.46, a decrease of 0.21% from the end of the previous year[5]. - The total liabilities amounted to ¥11,289,089,502.45, slightly up from ¥11,283,942,774.80 in the previous period[13]. - The company's total assets were reported at ¥12,210,396,757.46, slightly down from ¥12,235,892,212.67 in the previous period[13]. - The company's total liabilities decreased to ¥6,900,713,838.34 in Q1 2023 from ¥8,008,212,997.69 in Q4 2022, a decline of 13.8%[23]. - Non-current liabilities decreased from ¥1,374,550,017.57 to ¥1,338,346,085.43, reflecting a reduction of approximately 2.6%[12]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 35,053[8]. - The largest shareholder, Zhu Yicai, holds 42.25% of the shares, totaling 476,687,416 shares, which are currently frozen[8]. - The total equity attributable to shareholders was ¥892,241,363.25, down from ¥921,344,551.70 in the previous period[13]. - The company's total equity remains stable, with no significant changes reported in the equity section of the balance sheet[11]. Operational Metrics - Total operating costs for Q1 2023 were ¥644,282,835.14, down from ¥650,822,682.17 in Q1 2022, reflecting a reduction of 1.5%[15]. - The company reported a decrease in sales expenses to ¥89,579,953.59 from ¥73,529,014.56 in Q1 2022, an increase of 21.8%[15]. - Sales expenses rose to ¥31,451,906.26 in Q1 2023, up 69.0% from ¥18,606,496.56 in Q1 2022[25]. - Financial expenses for Q1 2023 were ¥73,426,297.52, a decrease from ¥76,567,982.84 in Q1 2022[15]. - Financial expenses decreased to ¥24,899,779.20 in Q1 2023 from ¥25,085,433.85 in Q1 2022, with interest expenses dropping significantly to ¥43,958,514.16 from ¥63,704,690.13[25]. Investment Activities - The net cash outflow from investing activities was ¥12,339,778.62 in Q1 2023, compared to a smaller outflow of ¥3,466,174.70 in Q1 2022[28]. - The net cash flow from investing activities was -¥13,765,602.02, an improvement from -¥29,993,233.35 in the same period last year[18]. Other Information - The company has not reported any new product launches or technological advancements during this quarter[10]. - There are no significant mergers or acquisitions announced in the current reporting period[10].